Prognostic and predictive value ofTP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial

✍ Scribed by Lynnette Fernández-Cuesta, Catherine Oakman, Priscila Falagan-Lotsch, Ke-seay Smoth, Emmanuel Quinaux, Marc Buyse, M Stella Dolci, Evandro De Azambuja, Pierre Hainaut, Patrizia Dell’Orto, Denis Larsimont, Prudence A Francis, John Crown, Martine Piccart-Gebhart, Giuseppe Viale, et al

• Book ID: 118726900
• Publisher: BioMed Central
• Year: 2012
• Tongue: English
• Weight: 307 KB
• Volume: 14
• Category: Article
• ISSN: 1465-5411
• DOI: 10.1186/bcr3179